Mucosal and systemic immune responses to Mycobacterium tuberculosis antigen 85A following its co-delivery with CpG, MPLA or LTB to the lungs in mice.
Pulmonary vaccination is a promising route for immunization against tuberculosis because the lung is the natural site of infection with Mycobacterium tuberculosis. Yet, adjuvants with a suitable safety profile need to be found to enhance mucosal immunity to recombinant antigens. The aim of this stud...
Main Authors: | Julie Todoroff, Muriel M Lemaire, Catherine Fillee, Fabienne Jurion, Jean-Christophe Renauld, Kris Huygen, Rita Vanbever |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3651129?pdf=render |
Similar Items
-
CpG-ODN and MPLA prevent mortality in a murine model of post-hemorrhage-Staphyloccocus aureus pneumonia.
by: Antoine Roquilly, et al.
Published: (2010-01-01) -
Evaluation of immunological responses against outer membrane vesicles (OMV) of nontypeable Haemophilus influenzae using MPLA-CpG adjuvant as a vaccine candidate
by: Ava Behrouzi, et al.
Published: (2020-10-01) -
Development of mucosal subunit vaccine with PEDV-S domain fusion with LTB
by: Luu Thi Nguyet Minh, et al.
Published: (2018) -
CpG Oligonukleotide:
by: Wagner, Moritz
Published: (2007) -
In vivo control of CpG and non-CpG DNA methylation by DNA methyltransferases.
by: Julia Arand, et al.
Published: (2012-06-01)